Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
32.65
+0.21 (0.65%)
May 12, 2026, 3:00 PM CST

SHA:688076 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,25311,91511,4119,5834,8908,811
Market Cap Growth
-2.69%4.42%19.08%95.95%-44.50%-
Enterprise Value
11,69713,44312,1079,7724,7268,238
Last Close Price
32.4437.7036.5631.4015.9428.55
PE Ratio
33.1735.8428.2258.8137.8876.36
Forward PE
15.3917.4420.2550.6531.8630.20
PS Ratio
5.316.137.029.277.5113.68
PB Ratio
3.283.974.254.382.544.87
P/TBV Ratio
3.724.464.765.042.955.64
P/OCF Ratio
15.0017.4928.5227.36166.9548.75
EV/Sales Ratio
6.066.927.459.467.2612.79
EV/EBITDA Ratio
13.1915.7318.2730.2727.7241.45
EV/EBIT Ratio
20.9224.3526.2751.1565.8470.35
Debt / Equity Ratio
0.760.890.610.410.170.05
Debt / EBITDA Ratio
2.743.112.452.741.860.41
Net Debt / Equity Ratio
0.460.540.320.07-0.06-0.33
Net Debt / EBITDA Ratio
1.651.911.300.45-0.72-3.00
Net Debt / FCF Ratio
-2.88-2.38-1.25-0.470.3011.32
Asset Turnover
0.320.330.380.340.280.37
Inventory Turnover
1.011.011.201.271.071.41
Quick Ratio
0.700.720.761.081.262.99
Current Ratio
1.171.161.141.541.914.01
Return on Equity (ROE)
10.21%11.45%16.41%8.04%6.58%7.84%
Return on Assets (ROA)
5.50%5.84%6.68%3.93%1.93%4.15%
Return on Invested Capital (ROIC)
10.71%12.19%14.29%8.82%4.75%8.90%
Return on Capital Employed (ROCE)
11.50%12.10%13.90%7.40%3.60%6.30%
Earnings Yield
3.02%2.79%3.54%1.70%2.64%1.31%
FCF Yield
-4.85%-5.75%-6.05%-3.24%-8.37%-0.60%
Dividend Yield
1.98%-1.76%0.91%0.90%0.38%
Payout Ratio
79.70%72.08%29.37%35.36%31.43%5.24%
Buyback Yield / Dilution
-2.28%-1.92%-2.52%-1.28%-10.06%-19.95%
Total Shareholder Return
-0.28%-1.92%-0.76%-0.37%-9.17%-19.58%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.